Abstract:Early initiated adequate antibiotic treatment is essential in intensive care. Shortening the length of antibiotic susceptibility testing (AST) can accelerate clinical decision-making. Our objective was to develop a simple flow cytometry (FC)-based AST that produces reliable results within a few hours. We developed a FC-based AST protocol (MICy) and tested it on six different bacteria strains (Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pyogenes, Enterococcus faecalis) in Mueller-Hinton and Luria-Bertani broth. We monitored the bacterial growth by FC to define the optimal time of AST. All bacteria were tested against 12 antibiotics and the MIC values were compared to microdilution used as reference method. McNemar and Fleiss' kappa inter-observer tests were performed to analyze the bias between the two methods. Susceptibility profiles of the two methods were also compared. We found that FC is able to detect the bacterial growth after 4-h incubation. The point-by-point comparison of MICy and microdilution resulted in exact match above 87% (2642/3024) of all measurements. The MIC values obtained by MICy and microdilution agreed over 80% (173/216) within ±1 dilution range that gives a substantial inter-observer agreement with weighted Fleiss' kappa. By using the EUCAST clinical breakpoints, we defined susceptibility profiles of MICy that were identical to microdilution in more than 92% (197/213) of the decisions. MICy resulted 8.7% major and 3.2% very major discrepancies. MICy is a new, simple FC-based AST method that produces susceptibility profile with low failure rate a workday earlier than the microdilution method. IMPORTANCE MICy is a new, simple and rapid flow cytometry based antibiotic susceptibility testing (AST) method that produces susceptibility profile a workday earlier than the microdilution method or other classical phenotypic AST methods. Shortening the length of AST can accelerate clinical decision-making as targeted antibiotic treatment improves clinical outcomes and reduces mortality, duration of artificial ventilation, and length of stay in intensive care unit. It can also reduce nursing time and costs and the spreading of antibiotic resistance. In this study, we present the workflow and methodology of MICy and compare the results produced by MICy to microdilution step by step.

A Novel Method for the Dynamic Analysis of Antimicrobial Effect

Development of an In-House Rapid Antimicrobial Susceptibility Testing Protocol for Positive Blood Culture and Its Implementation in Routine Microbiology Laboratories

Phase Contrast Image-Based Rapid Antimicrobial Susceptibility Testing of Bacteria in Liquid Culture Media

Controlled-diffusion centrifugal microfluidic for rapid antibiotic susceptibility testing

MICy: a Novel Flow Cytometric Method for Rapid Determination of Minimal Inhibitory Concentration

A capillary-based centrifugal indicator equipped with in-situ pathogenic bacteria culture for fast antimicrobial susceptibility testing

Rapid Antibiotic Susceptibility Testing of Bacteria by Single-Field Tracking Centrifugation of Bacteria Solution

Label-free single-cell antimicrobial susceptibility testing in droplets with concentration gradient generation

Rapid Antimicrobial Susceptibility Testing by Stimulated Raman Scattering Metabolic Imaging and Morphological Deformation of Bacteria

Progress in antibiotic susceptibility tests: a comparative review with special emphasis on microfluidic methods

Rapid Determination of Antibiotic Susceptibility of Clinical Isolates of Escherichia Coli by SYBR Green I/Propidium Iodide Assay

Agreement of methods to assess antimicrobial susceptibility using Escherichia coli isolates as target models

An Integrated Microfluidic Chip-Mass Spectrometry System for Rapid Antimicrobial Resistance Analysis of Bacteria Producing Β-Lactamases

A simple, inexpensive, and rapid method to assess antibiotic effectiveness against exoelectrogenic bacteria

Rapid and Accurate Antimicrobial Susceptibility Testing Using Label-Free Electrical Impedance-Based Microfluidic Platform

Combinatorial Screening SlipChip for Rapid Phenotypic Antimicrobial Susceptibility Testing

Recent Development of Rapid Antimicrobial Susceptibility Testing Methods through Metabolic Profiling of Bacteria

Inoculum Size-Insensitive Susceptibility Determination of Urine Sample Based on In-Situ Measurement of Inducible Enzyme Activity after 20 Min of Antibiotic Exposure

Categorizing microbial growth inhibition through quantification of 16S rRNA growth marker with stripwells covering a spectrum of antimicrobial conditions

On-chip MIC by Combining Concentration Gradient Generator and Flanged Chamber Arrays

Microfluidic Technologies for Advanced Antimicrobial Susceptibility Testing